Increased circulating Th17 cell populations in patients with pancreatic ductal adenocarcinoma

Bilska M, Pawłowska A, Zakrzewska E, Chudzik A, Suszczyk D, Gogacz M et al (2020) Th17 Cells and IL-17 as novel immune targets in ovarian cancer therapy. J Oncol e8797683. https://doi.org/10.1155/2020/8797683

Cascão R, Moura RA, Perpétuo I, Canhão H, Vieira-Sousa E, Mourão AF et al (2010) Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis. Arthritis Res Ther 12:R196. https://doi.org/10.1186/ar3168

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castro G, Liu X, Ngo K, De Leon-Tabaldo A, Zhao S, Luna-Roman R et al (2017) RORγt and RORα signature genes in human Th17 cells. PLoS One 12:e0181868. https://doi.org/10.1371/journal.pone.0181868

Charles KA, Kulbe H, Soper R, Escorcio-Correia M, Lawrence T, Schultheis A et al (2009) The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans. J Clin Invest 119:3011–3023. https://doi.org/10.1172/JCI39065

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen P, Wang M, Li D, Jia Y, He N, Li W et al (2015) The Alteration and Clinical Significance of Th22/Th17/Th1 Cells in Patients with Chronic Myeloid Leukemia. J Immunol Res 2015:16123. https://doi.org/10.1155/2015/416123

Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, Kang HS et al (2009) Critical regulation of early Th17 cell differentiation by IL-1 signaling. Immunity 30:576–587. https://doi.org/10.1016/j.immuni.2009.02.007

Article  CAS  PubMed  PubMed Central  Google Scholar 

Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy - Dimensions. [cited 28 Mar 2021]. Available: https://app.dimensions.ai/details/patent/US-9272057-B2

Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul J-L et al (2018) FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. N Engl J Med 379:2395–2406. https://doi.org/10.1056/NEJMoa1809775

Article  CAS  PubMed  Google Scholar 

De Simone V, Pallone F, Monteleone G, Stolfi C (2013) Role of TH17 cytokines in the control of colorectal cancer. Oncoimmunology 2:e26617. https://doi.org/10.4161/onci.26617

Duan Z, Miller HD, Fu X, Ge D, Jin B, Moustafa AA et al (2019) Th17 cells promote tumor growth in an immunocompetent orthotopic mouse model of prostate cancer. Am J Clin Exp Urol 7:249–261

PubMed  PubMed Central  Google Scholar 

Egwuagu CE (2009) STAT3 in CD4+ T helper cell differentiation and inflammatory diseases. Cytokine 47:149–156. https://doi.org/10.1016/j.cyto.2009.07.003

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elessawi DF, Alkady MM, Ibrahim IM (2019) Diagnostic and prognostic value of serum IL-23 in colorectal cancer. Arab J Gastroenterol 20:65–68. https://doi.org/10.1016/j.ajg.2019.05.002

Article  PubMed  Google Scholar 

Fouser LA, Wright JF, Dunussi-Joannopoulos K, Collins M (2008) Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol Rev 226:87–102. https://doi.org/10.1111/j.1600-065X.2008.00712.x

Article  CAS  PubMed  Google Scholar 

Gnerlich JL, Mitchem JB, Weir JS, Sankpal NV, Kashiwagi H, Belt BA et al (2010) Induction of Th17 cells in the tumor microenvironment improves survival in a murine model of pancreatic cancer. J Immunol 185:4063–4071. https://doi.org/10.4049/jimmunol.0902609

Article  CAS  PubMed  Google Scholar 

He S, Fei M, Wu Y, Zheng D, Wan D, Wang L et al (2011) Distribution and Clinical Significance of Th17 Cells in the Tumor Microenvironment and Peripheral Blood of Pancreatic Cancer Patients. Int J Mol Sci 12:7424. https://doi.org/10.3390/ijms12117424

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hirota K, Martin B, Veldhoen M (2010) Development, regulation and functional capacities of Th17 cells. Semin Immunopathol 32:3–16. https://doi.org/10.1007/s00281-009-0187-y

Article  CAS  PubMed  Google Scholar 

Huang J, Lok V, Ngai CH, Zhang L, Yuan J, Lao XQ et al (2021) Worldwide Burden of, Risk Factors for, and Trends in Pancreatic Cancer. Gastroenterology 160:744–754. https://doi.org/10.1053/j.gastro.2020.10.007

Article  PubMed  Google Scholar 

Iida T, Iwahashi M, Katsuda M, Ishida K, Nakamori M, Nakamura M et al (2011) Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer. Oncol Rep 25:1271–1277. https://doi.org/10.3892/or.2011.1201

Article  CAS  PubMed  Google Scholar 

Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ et al (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126:1121–1133. https://doi.org/10.1016/j.cell.2006.07.035

Article  CAS  PubMed  Google Scholar 

Karabulut S, Afsar ÇU, Karabulut M, Alış H, Kılıc L, Çikot M et al (2016) Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma. J Gastrointest Cancer 47:47–54. https://doi.org/10.1007/s12029-015-9787-z

Article  CAS  PubMed  Google Scholar 

Karpisheh V, Ahmadi M, Abbaszadeh-Goudarzi K, Mohammadpour Saray M, Barshidi A, Mohammadi H et al (2022) The role of Th17 cells in the pathogenesis and treatment of breast cancer. Cancer Cell Int 22:108. https://doi.org/10.1186/s12935-022-02528-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27:485–517. https://doi.org/10.1146/annurev.immunol.021908.132710

Article  CAS  PubMed  Google Scholar 

Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S et al (2009) Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114:1141–1149. https://doi.org/10.1182/blood-2009-03-208249

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kryczek I, Wei S, Zou L, Altuwaijri S, Szeliga W, Kolls J et al (2007) Cutting Edge: Th17 and Regulatory T Cell Dynamics and the Regulation by IL-2 in the Tumor Microenvironment. J Immunol 178:6730–6733. https://doi.org/10.4049/jimmunol.178.11.6730

Article  CAS  PubMed  Google Scholar 

Lafdil F, Miller AM, Ki SH, Gao B (2010) Th17 cells and their associated cytokines in liver diseases. Cell Mol Immunol 7:250–254. https://doi.org/10.1038/cmi.2010.5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liao Y, Wang B, Huang Z-L, Shi M, Yu X-J, Zheng L et al (2013) Increased circulating Th17 cells after transarterial chemoembolization correlate with improved survival in stage III hepatocellular carcinoma: a prospective study. PLoS One 8:e60444. https://doi.org/10.1371/journal.pone.0060444

Li Y, Jie Y, Wang X, Lu J (2021) Serum IL-35 is decreased in overweight patients with rheumatoid arthritis: its correlation with Th1/Th2/Th17-related cytokines. BMC Immunol 22:42. https://doi.org/10.1186/s12865-021-00431-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu J, Duan Y, Cheng X, Chen X, Xie W, Long H et al (2011) IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochem Biophys Res Commun 407:348–354. https://doi.org/10.1016/j.bbrc.2011.03.021

Article  CAS  PubMed  Google Scholar 

Loncle C, Bonjoch L, Folch-Puy E, Lopez-Millan MB, Lac S, Molejon MI et al (2015) IL17 Functions through the Novel REG3β-JAK2-STAT3 Inflammatory Pathway to Promote the Transition from Chronic Pancreatitis to Pancreatic Cancer. Cancer Res 75:4852–4862. https://doi.org/10.1158/0008-5472.CAN-15-0896

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu X, Jin H, Zhang G, Lin X, Chen C, Sun J et al (2014) Intratumor IL-17-positive mast cells are the major source of the IL-17 that is predictive of survival in gastric cancer patients. PLoS One 9:e106834. https://doi.org/10.1371/journal.pone.0106834

Lu T, Yu S, Liu Y, Yin C, Ye J, Liu Z et al (2016) Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin’s Lymphoma. Bertolini F, editor. PLoS One 11:e0148044. https://doi.org/10.1371/journal.pone.0148044

McAllister F, Leach SD (2014) Targeting IL-17 for pancreatic cancer prevention. Oncotarget 5:9530–9531

Article  PubMed  PubMed Central  Google Scholar 

Muranski P, Boni A, Antony PA, Cassard L, Irvine KR, Kaiser A et al (2008) Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112:362–373. https://doi.org/10.1182/blood-2007-11-120998

Article  CAS  PubMed  PubMed Central  Google Scholar 

Muranski P, Restifo NP (2013) Essentials of Th17 cell commitment and plasticity. Blood 121:2402–2414. https://doi.org/10.1182/blood-2012-09-378653

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miossec P (2009) IL-17 and Th17 cells in human inflammatory diseases. Microbes Infect 11:625–630. https://doi.org/10.1016/j.micinf.2009.04.003

Article  CAS  PubMed  Google Scholar 

Neoptolemos JP, Stocken DD, Bassi C, Ghaneh P, Cunningham D, Goldstein D et al (2010) Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA 304:1073–1081. https://doi.org/10.1001/jama.2010.1275

Article  CAS  PubMed  Google Scholar 

Parikh PY, Lillemoe KD (2015) Surgical Management of Pancreatic Cancer—Distal Pancreatectomy. Semin Oncol 42:110–122. https://doi.org/10.1053/j.seminoncol.2014.12.010

Article  PubMed  Google Scholar 

Pan B, Shen J, Cao J, Zhou Y, Shang L, Jin S et al (2015) Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3/GIV signaling pathway in non-small-cell lung cancer. Sci Rep 5:16053. https://doi.org/10.1038/srep16053

Article  CAS  PubMed  PubMed Central  Google Scholar 

Petermann F, Rothhammer V, Claussen MC, Haas JD, Blanco LR, Heink S et al (2010) γδ T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. Immunity 33:351–363. https://doi.org/10.1016/j.immuni.2010.08.013

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rauen T, Juang Y-T, Hedrich CM, Kis-Toth K, Tsokos GC (2012) A novel isoform of the orphan receptor RORγt suppresses IL-17 production in human T cells. Genes Immun 13:346–350. https://doi.org/10.1038/gene.2011.85

Article 

留言 (0)

沒有登入
gif